Evaluation of Cognitive Behavioral Therapy for Long-term Pain in Rheumatic Disease, Including Validation of AE-FS
2 other identifiers
interventional
200
1 country
1
Brief Summary
Catastrophic thinking is a risk factor for a poor prognosis for pain in general and rheumatic disease in particular, which for many contributes to a behavioral pattern characterized by avoidance. Other people with long-term pain, on the other hand, have a pattern where they suppress thoughts and feelings of fear associated with pain, and push themselves to carry out activities. An inappropriate form of endurance can help maintain and intensify pain. The AE-FS is a short version of the Avoidance-Endurance Questionnaire with different subscales for maintaining activity despite pain. AE-FS can be of great clinical utility. The study of patients with rheumatic disease and long-term pain will validate a Norwegian version of the AE-FS as well as examine how the AE-FS seen in connection with other relevant questionnaires, including the Pain Catastrophizing Scale , reflects mechanisms for change in cognitive behavioral therapy for long-term pain. The effect of the intervention is evaluated with questionnaires at baseline/start of treatment, end of treatment, two months after end of treatment and after six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2024
CompletedFirst Submitted
Initial submission to the registry
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
May 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
October 15, 2024
October 1, 2024
4 years
January 17, 2024
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Validation of AE-FS
1\. The AE-FS questionnaire can be of great clinical value for mapping behavior and thoughts in mild and severe pain, both to predict long-term pain and as an educational tool in the treatment of patients. In the project, we will validate the form, by assessing its suitability for our patient group and compliance with other validated forms which, among other things, measure pain, depressive symptoms, anxiety symptoms and function.
8 months
Evaluation of cognitive behavioral therapy for long-term pain in rheumatic disease - Feasibility
In the project, we also to evaluate the feasibility of the treatment:Feasibility and satisfaction, including attendance, dropouts, etc.
8 months
Evaluation of cognitive behavioral therapy for long-term pain in rheumatic disease - Pain
Pain, measured by the Brief Pain Inventory questionnaire - short form
8 months
Evaluation of cognitive behavioral therapy for long-term pain in rheumatic disease - General symptoms
General symptoms, measured by the PROMIS-29 questionnaire (Patient reported outcomes measurement information system).
8 months
Evaluation of cognitive behavioral therapy for long-term pain in rheumatic disease - Quality of life
Quality of life/general health, measured by the EQ-5D-5L questionnaire (general health questionnaire).
8 months
Secondary Outcomes (1)
Analyses of predictors and mediators
8 months
Study Arms (1)
Cognitive behavioral Therapy
EXPERIMENTALCognitive behavioral therapy is the psychological approach in this study. It is associated with better outcomes of rehabilitation for long-term pain in general, reduced pain intensity and less use of medication and health services, sustaining factors that provide an understanding of how thoughts and feelings affect the experience of pain. An important aim is also a reduction in pain-related rumination and worry and changed metacognition that maintains inhibiting behavior and thought patterns. A workbook for pain has been developed. It contains knowledge about pain and pain management, describes measures and homework from session to session. The treatment consists of 8 sessions with 7 weekly sessions + 1 booster session 2 months after the end of treatment.
Interventions
Cognitive behavioral therapy is the psychological approach in this study. It is associated with better outcomes of rehabilitation for long-term pain in general, reduced pain intensity and less use of medication and health services, sustaining factors that provide an understanding of how thoughts and feelings affect the experience of pain. An important aim is also a reduction in pain-related rumination and worry and changed metacognition that maintains inhibiting behavior and thought patterns. A workbook for pain has been developed. It contains knowledge about pain and pain management, describes measures and homework from session to session. The treatment consists of 8 sessions with 7 weekly sessions + 1 booster session 2 months after the end of treatment. .
Eligibility Criteria
You may qualify if:
- A rheumatic disorder and a long term pain condition
- Written consent
You may not qualify if:
- Participation in another therapy during the study periode
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diakonhjemmet Sykehus
Oslo, 0319, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Erik Soegaard, PhD
Diakonhjemmet Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher PhD MD
Study Record Dates
First Submitted
January 17, 2024
First Posted
May 14, 2024
Study Start
January 16, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2030
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
IPD are not to be shared with other researshers